XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
Hangzhou Gaoxin Materials Technology
300478
Beijing Philisense Technology
300287
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||
Goods sale service render cash | 25.49%1.16B | 23.17%801.26M | 4.99%174.9M | 20.16%1.17B | 22.39%920.38M | 33.77%650.53M | --166.59M | 47.14%969.57M | --751.99M | --486.3M |
Refunds of taxes and levies | ---- | ---- | ---- | -89.93%1.32M | -89.66%1.32M | -89.66%1.32M | ---- | --13.07M | --12.72M | --12.72M |
Cash received relating to other operating activities | -13.25%9.13M | 22.54%7.92M | 974.12%5.91M | -13.56%10.48M | 17.89%10.52M | -20.71%6.47M | --550.65K | 101.85%12.12M | --8.92M | --8.15M |
Cash inflows from operating activities | 24.88%1.16B | 22.92%809.18M | 8.18%180.82M | 18.30%1.18B | 20.50%932.22M | 29.80%658.32M | --167.14M | 49.60%994.77M | --773.64M | --507.18M |
Goods services cash paid | 50.61%530.31M | 38.53%370.29M | -8.80%95.04M | 1.13%441.89M | 6.17%352.1M | 21.41%267.31M | --104.21M | 51.29%436.98M | --331.64M | --220.18M |
Staff behalf paid | 21.54%94.65M | 14.28%64.15M | 4.43%28.4M | 19.75%106.28M | 21.97%77.88M | 36.05%56.14M | --27.2M | 61.32%88.75M | --63.85M | --41.26M |
All taxes paid | 29.33%136.46M | 33.07%90.73M | -39.82%19.64M | 42.61%129.11M | 56.55%105.51M | 255.04%68.19M | --32.63M | 54.78%90.54M | --67.4M | --19.21M |
Cash paid relating to other operating activities | 7.97%223.08M | 3.17%143.14M | 80.91%66.06M | 15.86%246.99M | 20.46%206.61M | 30.52%138.75M | --36.52M | 71.97%213.18M | --171.52M | --106.3M |
Cash outflows from operating activities | 32.66%984.51M | 26.01%668.32M | 4.28%209.13M | 11.43%924.28M | 16.98%742.11M | 37.07%530.38M | --200.55M | 57.60%829.44M | --634.4M | --386.94M |
Net cash flows from operating activities | -5.52%179.63M | 10.10%140.86M | 15.23%-28.32M | 52.74%252.52M | 36.54%190.11M | 6.40%127.94M | ---33.41M | 19.24%165.32M | --139.24M | --120.24M |
Investing cash flow | ||||||||||
Cash received from disposal of investments | 386.32%631.49M | 401.73%420.7M | -45.92%20.48M | 20.96%581.35M | -49.05%129.85M | -30.45%83.85M | --37.86M | 15.30%480.62M | --254.88M | --120.56M |
Cash received from returns on investments | 4,109.54%21.03M | 18,524.16%19.78M | 731.16%151.35K | 131.02%4.73M | -58.10%499.65K | -86.09%106.19K | --18.21K | -11.71%2.05M | --1.19M | --763.65K |
Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | ---- | ---- | ---- | -99.05%1.32K | ---- | ---- | ---- | 4,523.33%138.7K | ---- | ---- |
Cash inflows from investing activities | 400.59%652.52M | 424.65%440.47M | -45.54%20.63M | 21.39%586.08M | -49.10%130.35M | -30.80%83.96M | --37.88M | 15.18%482.81M | --256.07M | --121.32M |
Cash paid to acquire fixed assets intangible assets and other long-term assets | 307.08%45.29M | -17.80%8.2M | -69.29%1.97M | -66.42%13.65M | -53.28%11.13M | -54.59%9.97M | --6.43M | -73.26%40.65M | --23.81M | --21.96M |
Cash paid to acquire investments | 302.96%866.4M | 229.49%523.3M | 441.12%169.04M | 335.05%1.88B | -30.84%215.01M | -1.05%158.82M | --31.24M | 0.31%432.62M | --310.91M | --160.51M |
Cash outflows from investing activities | 303.16%911.69M | 214.87%531.49M | 354.04%171.01M | 300.56%1.9B | -32.44%226.14M | -7.50%168.8M | --37.66M | -18.86%473.27M | --334.72M | --182.47M |
Net cash flows from investing activities | -170.57%-259.17M | -7.29%-91.02M | -70,458.61%-150.39M | -13,838.06%-1.31B | -21.79%-95.79M | -38.74%-84.84M | --213.74K | 105.81%9.53M | ---78.65M | ---61.15M |
Financing cash flow | ||||||||||
Cash received from capital contributions | ---- | ---- | ---- | --995.48M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash inflows from financing activities | ---- | ---- | ---- | --995.48M | ---- | ---- | ---- | ---- | ---- | ---- |
Dividend interest payment | --68.78M | --68.78M | ---- | ---- | ---- | ---- | ---- | -88.89%3.44M | --3.44M | --3.4M |
Cash payments relating to other financing activities | 47.66%6.09M | 269.40%5.71M | -59.12%379.77K | 280.77%22.64M | -13.34%4.12M | -60.65%1.55M | --929.08K | -5.92%5.95M | --4.76M | --3.93M |
Cash outflows from financing activities | 1,715.22%74.87M | 4,718.72%74.49M | -59.12%379.77K | 141.25%22.64M | -49.69%4.12M | -78.92%1.55M | --929.08K | -74.82%9.39M | --8.2M | --7.33M |
Net cash flows from financing activities | -1,715.22%-74.87M | -4,718.72%-74.49M | 59.12%-379.77K | 10,465.50%972.84M | 49.69%-4.12M | 78.92%-1.55M | ---929.08K | -104.98%-9.39M | ---8.2M | ---7.33M |
Net cash flow | ||||||||||
Exchange rate change effecting cash and cash equivalents | ---312.24 | ---6.06 | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- |
Net increase in cash and cash equivalents | -271.20%-154.42M | -159.32%-24.65M | -424.81%-179.09M | -150.96%-84.32M | 72.17%90.2M | -19.71%41.55M | ---34.12M | 1.43%165.47M | --52.39M | --51.76M |
Add:Begin period cash and cash equivalents | -22.90%283.83M | -22.90%283.83M | -22.90%283.83M | 81.64%368.15M | 81.64%368.15M | 81.64%368.15M | --368.15M | 412.74%202.67M | --202.67M | --202.67M |
End period cash equivalent | -71.77%129.41M | -36.74%259.18M | -68.64%104.74M | -22.90%283.83M | 79.70%458.34M | 61.03%409.7M | --334.02M | 81.64%368.15M | --255.06M | --254.43M |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
Auditor | -- | -- | -- | Guangdong Sinong Accounting Firm (Special General Partnership) | -- | -- | -- | Rong Cheng Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.